Location: Munich, Germany, Booth #8
Start Date: Oct 15, 2025
End Date: Oct 17, 2025
Type of Event: Scientific Conferences
Attendees:

Join us in-person in Munich, Germany for the GSCN (German Stem Cell Network) Conference 2025, which Evotec is supporting as a Bronze Sponsor. Visit us at booth #8 to engage with our scientific experts, or join our various scientific contributions.

Evotec at GSCN Conference 2025

Oral Presentations

Off-the-shelf immune-shielded stem cell-derived macrophages for clinical applications 

Speaker: Stefanie Pfaender, Senior Research Scientist, Cell Therapy
Date and Time: Wednesday, 15 October, 15:15 - 15:30
Session: Stem cells in regenerative therapies; Plenary Hall      

Modulating reactive astrocytes in Alzheimer’s Disease

Speaker: Bastian Zimmer, VP iPSC Drug Discovery
Date and Time: Thursday, 16 October, 9:00 - 9:30
Session: Stem cells in disease modeling & drug development II; HPC   

Cell therapy at Evotec – end-to-end from process development to clinical manufacturing

Speaker: Matthias Austen, SVP, Cell Therapy
Date and Time: Thursday, 16 October, 11:45 - 12:05
Session: Industry session: "Technologies from GSCN industry partners" III; LH23   

Poster Presentations

Development of GMP-compatible genetically modified iPSC-derived macrophages for off-the-shelf cell therapy

Presenter: Alica Hinkelmann, Research Assistant, Cell Therapy
Poster Number: P130
Date and Time: Thursday, 16 October, 4.30 pm - 5:30 pm

Modeling and reversing Alzheimer’s-associated microglial states using iPSC-derived cells and disease-linked gene signatures

Presenter: Bastian Zimmer, VP iPSC Drug Discovery
Poster Number: P124
Date and Time: Thursday, 16 October, 4.30 pm - 5:30 pm

An innovative human iPSC cardiomyocyte platform to accelerate cardiac drug discovery and target validation

Presenter: Benjamin Fischer, Research Scientist, iPSC Drug Discovery
Poster Number: P091
Date and Time: Thursday, 16 October, 5.30 pm - 6:30 pm

Off-the-shelf immune-shielded stem cell-derived γδ T cells for clinical applications

Presenter: Tommaso Pezzica, Research Assistant, iPSC Cell Therapy
Poster Number: P139
Date and Time: Thursday, 16 October, 5.30 pm - 6:30 pm

Arrange a Meeting with Us

TODO

iPSC Drug Discovery

The industry-leading human iPSC-based drug screening platform which can model diseases in more than 15 cell types. Patient-derived cell-based assays and an enhanced molecular understanding of disease phenotypes are crucial to improving the accuracy of this disease modelling

Learn more
TODO

iPSC Cell Therapy

Your Partner to Accelerate iPSC-based Cell Therapy Development

Learn more